scispace - formally typeset
D

David Cohen

Researcher at Pierre-and-Marie-Curie University

Publications -  787
Citations -  45536

David Cohen is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 83, co-authored 635 publications receiving 37722 citations. Previous affiliations of David Cohen include University of California, Berkeley & University of Michigan.

Papers
More filters
Journal ArticleDOI

A Systematic Review of the Evidence for Impaired Cognitive Theory of Mind in Maltreated Children

TL;DR: Measures of psychopathology and other cognitive abilities, in addition to ToM, are required to establish a specific association between maltreatment and the cognitive dimension of ToM.
Journal ArticleDOI

Law, Autonomy, and Political Community in Plato's Laws

David Cohen
- 01 Oct 1993 - 
TL;DR: In this article, the authors focus on the Republic and do not take into account the distinct conception of political community that Plato develops in the Laws, and they do not consider the fact that the principle of the rule of the wisest and best cannot be implemented because only a god would have the qualities necessary for its fulfillment.
Journal ArticleDOI

Presence of autism, hyperserotonemia, and severe expressive language impairment in Williams-Beuren syndrome

TL;DR: It is indicated that behaviors and neurochemical phenotypes typically associated with autism can occur in patients with common WBSCR deletions, and the results raise intriguing questions about phenotypic heterogeneity in WBS and regarding genetic and/or environmental factors interacting with specific genes at 7q11.23 sensitive to dosage alterations that can influence the development of social communication skills.
Journal ArticleDOI

Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results

TL;DR: The Multi‐center Prospective Study to Evaluate Outcomes of Moderate to Severely Calcified Coronary Lesions (MACE—Trial) was designed to provide further insight on the impact of calcification on procedural and long‐term percutaneous coronary intervention outcomes.